308 related articles for article (PubMed ID: 25933165)
21. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
22. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Chen A; Zhao B; Kieff E; Aster JC; Wang F
J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
24. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
25. Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
Habeshaw G; Yao QY; Bell AI; Morton D; Rickinson AB
J Virol; 1999 Feb; 73(2):965-75. PubMed ID: 9882297
[TBL] [Abstract][Full Text] [Related]
26. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
27. Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases.
Correia S; Bridges R; Wegner F; Venturini C; Palser A; Middeldorp JM; Cohen JI; Lorenzetti MA; Bassano I; White RE; Kellam P; Breuer J; Farrell PJ
J Virol; 2018 Nov; 92(22):. PubMed ID: 30111570
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brazil and the United Kingdom.
MacKenzie J; Gray D; Pinto-Paes R; Barrezueta LFM; Armstrong AA; Alexander FA; McGeoch DJ; Jarrett RF
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2741-2745. PubMed ID: 10573169
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
Aitken C; Sengupta SK; Aedes C; Moss DJ; Sculley TB
J Gen Virol; 1994 Jan; 75 ( Pt 1)():95-100. PubMed ID: 8113744
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma.
Fassone L; Cingolani A; Martini M; Migliaretti G; Oreste PL; Capello D; Gloghini A; Vivenza D; Dolcetti R; Carbone A; Antinori A; Gaidano G; Larocca LM
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):19-26. PubMed ID: 11804553
[TBL] [Abstract][Full Text] [Related]
32. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
33. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
Bornkamm GW
Int J Cancer; 2009 Apr; 124(8):1745-55. PubMed ID: 19165855
[TBL] [Abstract][Full Text] [Related]
35. Quantitative and qualitative RNA-Seq-based evaluation of Epstein-Barr virus transcription in type I latency Burkitt's lymphoma cells.
Lin Z; Xu G; Deng N; Taylor C; Zhu D; Flemington EK
J Virol; 2010 Dec; 84(24):13053-8. PubMed ID: 20943983
[TBL] [Abstract][Full Text] [Related]
36. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
37. Burkitt's Lymphoma.
Rochford R; Moormann AM
Curr Top Microbiol Immunol; 2015; 390(Pt 1):267-85. PubMed ID: 26424650
[TBL] [Abstract][Full Text] [Related]
38. Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children.
Ai J; Xie Z; Liu C; Huang Z; Xu J
Virol J; 2012 Jan; 9():13. PubMed ID: 22236445
[TBL] [Abstract][Full Text] [Related]
39. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma.
Okano M; Aya T; Mizuno F; Takada K; Osato T
Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328
[TBL] [Abstract][Full Text] [Related]
40. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
